MP14-04 PREOPERATIVE TUMOR MEASUREMENTS ARE INDEPENDENTLY PREDICTIVE OF OVERALL SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000839.04
Abstract: INTRODUCTION AND OBJECTIVE: Studies suggest that overall survival (OS) following cytoreductive nephrectomy (CN) is associated with preoperative tumor measurements including primary tumor diameter, number of metastatic sites, sum of metastatic tumor diameters and primary tumor… read more here.
Keywords: tumor measurements; risk; burden; preoperative tumor ... See more keywords
Abstract A040: Multi-site sequencing of lethal prostate cancer reveals metastatic dissemination by independent and early-branching clones
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.prca2023-a040
Abstract: Primary prostate cancer (PCa) is frequently multifocal (genetically independent(GI) clones) and is further characterized by extensive intratumoral heterogeneity (genetically related clones). In metastatic castrate resistant PCa (mCRPC) monoclonal and polyclonal seeding of metastatic sites by… read more here.
Keywords: prostate cancer; metastatic dissemination; early branching; metastatic sites ... See more keywords
The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0230060
Abstract: The real impact of specific sites of metastasis on prognosis of metastatic pancreatic cancer (MPC) is unknown. To evaluate the association of specific metastatic sites and survival outcomes in MPC a systematic literature review was… read more here.
Keywords: metastatic sites; prospective randomized; impact; review ... See more keywords
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines11010083
Abstract: Background: ICIs have dramatically improved patient outcomes in different malignancies. However, the impact of liver metastases (LM) and number of metastatic sites (MS) remains unclear in patients treated with single-agent anti-PD(L)1. Methods: We aimed to… read more here.
Keywords: metastatic sites; metastases number; number; impact liver ... See more keywords